39
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Physostigmine Versus Naloxone in Heroin -Overdose

, , , &
Pages 387-397 | Published online: 25 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Stephen J. Traub, Lewis S. Nelson & Robert S. Hoffman. (2002) Physostigmine as a Treatment for Gamma-Hydroxybutyrate Toxicity: A Review. Journal of Toxicology: Clinical Toxicology 40:6, pages 781-787.
Read now
Joseph J. Osterwalder. (1996) Naloxone–For Intoxications with Intravenous Heroin and Heroin Mixtures-Harmless or Hazardous? A Prospective Clinical Study. Journal of Toxicology: Clinical Toxicology 34:4, pages 409-416.
Read now
Larrel W. Harris, Dana R. Anderson, Anita M. Pastelak, Susan L. Bowersox, Beth A. Vanderpool & Willard J. Lennox. (1992) Acetylcholinesterase Inhibition and Anti-Soman Efficacy of Homologs of Physostigmine. Drug and Chemical Toxicology 15:2, pages 127-143.
Read now

Articles from other publishers (15)

Wenwen Shen, Disen Mei, Yue Liu & Wenhua Zhou. 2022. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions 1831 1849 .
Wenwen Shen, Disen Mei, Yue Liu & Wenhua Zhou. 2021. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions 1 19 .
Olivia Magwood, Ginetta Salvalaggio, Michaela Beder, Claire Kendall, Victoire Kpade, Wahab Daghmach, Gilbert Habonimana, Zack Marshall, Ellen Snyder, Tim O’Shea, Robin Lennox, Helen Hsu, Peter Tugwell & Kevin Pottie. (2020) The effectiveness of substance use interventions for homeless and vulnerably housed persons:  A systematic review of systematic reviews on supervised consumption facilities, managed alcohol programs, and pharmacological agents for opioid use disorder. PLOS ONE 15:1, pages e0227298.
Crossref
Ann M. Arens & Tom Kearney. (2019) Adverse Effects of Physostigmine. Journal of Medical Toxicology 15:3, pages 184-191.
Crossref
Anees Bahji & Neeraj Bajaj. (2018) Opioids on Trial: A Systematic Review of Interventions for the Treatment and Prevention of Opioid Overdose. Canadian Journal of Addiction 9:1, pages 26-33.
Crossref
William J. Boroughf. 2017. Critical Care Toxicology. Critical Care Toxicology 2943 2955 .
William J. Boroughf. 2016. Critical Care Toxicology. Critical Care Toxicology 1 14 .
Terry L. Vanden Hoek, Laurie J. Morrison, Michael Shuster, Michael Donnino, Elizabeth Sinz, Eric J. Lavonas, Farida M. Jeejeebhoy & Andrea Gabrielli. (2010) Part 12: Cardiac Arrest in Special Situations. Circulation 122:18_suppl_3.
Crossref
Laurie J. Morrison, Charles D. Deakin, Peter T. Morley, Clifton W. Callaway, Richard E. Kerber, Steven L. Kronick, Eric J. Lavonas, Mark S. Link, Robert W. Neumar, Charles W. Otto, Michael Parr, Michael Shuster, Kjetil Sunde, Mary Ann Peberdy, Wanchun Tang, Terry L. Vanden Hoek, Bernd W. Böttiger, Saul Drajer, Swee Han Lim, Jerry P. Nolan, Christophe Adrie, Mohammed Alhelail, Pavan Battu, Wilhelm Behringer, Lauren Berkow, Richard A. Bernstein, Sadiq S. Bhayani, Blair Bigham, Jeff Boyd, Barry Brenner, Eric Bruder, Hermann Brugger, Ian L. Cash, Maaret Castrén, Michael Cocchi, Gregory Comadira, Kate Crewdson, Michael S. Czekajlo, Suzanne R. Davies, Harinder Dhindsa, Deborah Diercks, C. Jessica Dine, Csaba Dioszeghy, Michael Donnino, Joel Dunning, Nabil El Sanadi, Heather Farley, Peter Fenici, V. Ramana Feeser, Jane A.H. Foster, Hans Friberg, Michael Fries, F. Javier Garcia-Vega, Romergryko G. Geocadin, Marios Georgiou, Jaspinder Ghuman, Melissa Givens, Colin Graham, David M. Greer, Henry R. Halperin, Amanda Hanson, Michael Holzer, Elizabeth A. Hunt, Masami Ishikawa, Marios Ioannides, Farida M. Jeejeebhoy, Paul A. Jennings, Hitoshi Kano, Karl B. Kern, Fulvio Kette, Peter J. Kudenchuk, Douglas Kupas, Giuseppe La Torre, Todd M. Larabee, Marion Leary, John Litell, Charles M. Little, David Lobel, Timothy J. Mader, James J. McCarthy, Michael C. McCrory, James J. Menegazzi, William J. Meurer, Paul M. Middleton, Allan R. Mottram, Eliano Pio Navarese, Thomas Nguyen, Marcus Ong, Andrew Padkin, Edison Ferreira de Paiva, Rod S. Passman, Tommaso Pellis, John J. Picard, Rachel Prout, Morten Pytte, Renee D. Reid, Jon Rittenberger, Will Ross, Sten Rubertsson, Malin Rundgren, Sebastian G. Russo, Tetsuya Sakamoto, Claudio Sandroni, Tommaso Sanna, Tomoyuki Sato, Sudhakar Sattur, Andrea Scapigliati, Richard Schilling, Ian Seppelt, Fred A. Severyn, Greene Shepherd, Richard D. Shih, Markus Skrifvars, Jasmeet Soar, Keiichi Tada, Sara Tararan, Michel Torbey, Jonathan Weinstock, Volker Wenzel, Christoph H. Wiese, Daniel Wu, Carolyn M. Zelop, David Zideman & Janice L. Zimmerman. (2010) Part 8: Advanced Life Support. Circulation 122:16_suppl_2.
Crossref
Charles D. Deakin, Laurie J. Morrison, Peter T. Morley, Clifton W. Callaway, Richard E. Kerber, Steven L. Kronick, Eric J. Lavonas, Mark S. Link, Robert W. Neumar, Charles W. Otto, Michael Parr, Michael Shuster, Kjetil Sunde, Mary Ann Peberdy, Wanchun Tang, Terry L. Vanden Hoek, Bernd W. Böttiger, Saul Drajer, Swee Han Lim & Jerry P. Nolan. (2010) Part 8: Advanced life support. Resuscitation 81:1, pages e93-e174.
Crossref
Theodore C. Bania & Jason Chu. (2005) Physostigmine Does Not Effect Arousal but Produces Toxicity in an Animal Model of Severe γ -hydroxybutyrate Intoxication . Academic Emergency Medicine 12:3, pages 185-189.
Crossref
Theodore C. Bania & Jason Chu. (2005) Physostigmine Does Not Effect Arousal but Produces Toxicity in an Animal Model of Severe γ-hydroxybutyrate Intoxication. Academic Emergency Medicine 12:3, pages 185-189.
Crossref
Kathleen M Beaver & Thomas J Gavin. (1998) Treatment of acute anticholinergic poisoning with physostigmine. The American Journal of Emergency Medicine 16:5, pages 505-507.
Crossref
A. PINELLI, S. TRIVULZIO & L. TOMASONI. (1997) Effects of Administration of Phentonium Bromide on Opioid Withdrawal Syndrome in Rats. Journal of Pharmacy and Pharmacology 49:12, pages 1222-1228.
Crossref
Paul G. Green & Ian Kitchen. (1986) Antinociception opioids and the cholinergic system. Progress in Neurobiology 26:2, pages 119-146.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.